Resources & Guides
Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.
GLP-1 Medication Hubs
Comprehensive guides for each GLP-1 medication—dosing protocols, clinical trial data, microdosing strategies, and our free calculators.
Semaglutide Guide
Ozempic & Wegovy: GLP-1 receptor agonist. ~15% weight loss, 7-day half-life. FDA-approved for diabetes and weight management.
Tirzepatide Guide
Mounjaro & Zepbound: Dual GLP-1/GIP agonist. ~21% weight loss, 5-day half-life. The first dual-agonist approved by FDA.
Retatrutide Guide
Triple GLP-1/GIP/Glucagon agonist. ~24% weight loss in trials, 6-day half-life. Expected FDA approval 2027.
Educational Content
Mounjaro GoodRx vs Savings Card: Which Is Cheaper in 2026?
articleMounjaro is approved for type 2 diabetes, and that single fact changes the whole coverage picture compared with weight-loss GLP-1s. This guide prices the GoodRx coupon against the manufacturer savings card and LillyDirect self-pay, then separates the card's government exclusion from whether Medicare, Medicaid, and TRICARE cover the drug itself.
Mounjaro Savings Card: How to Get $25/Month (2026 Guide)
articlePrescribed Mounjaro for type 2 diabetes? This guide walks the savings card eligibility tiers, enrollment steps, common reasons the card gets rejected, and the cash-pay alternatives if you cannot use it.
Mounjaro (Tirzepatide) Cost: 2026 Price, Savings & Coverage
articlePrescribed Mounjaro for type 2 diabetes and wondering what it will actually cost? This guide covers every pricing tier specific to T2D patients: list price, savings card, Medicare Part D coverage, prior authorisation, and the cheapest legitimate cash-pay route.